Differential expression of costimulatory molecules B7-1 and B7-2 on microglial cells induced by Th1 and Th2 cells in organotypic brain tissue

GLIA

Volumn 36, Issue 3, 2001, Pages 414-420

  Wolf, Susanne A ^a   Gimsa, Ulrike ^a   Bechmann, Ingo ^a   Nitsch, Robert ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

CD80 CD86 expression; Microglia; Th1 and Th2 costimulation

Indexed keywords

ANTIGEN; B7 2 PROTEIN; B7 ANTIGEN; B7-2 PROTEIN; EPITOPE; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; MYELIN BASIC PROTEIN; OVALBUMIN;

ANIMAL; ANTIGEN PRESENTATION; ARTICLE; BIOLOGICAL MODEL; BRAIN; COCULTURE; CYTOLOGY; DOWN REGULATION; GENE EXPRESSION REGULATION; IMMUNOLOGY; METABOLISM; MICROGLIA; MOUSE; MOUSE STRAIN; MULTIPLE SCLEROSIS; PATHOLOGY; PATHOPHYSIOLOGY; TH1 CELL; TH2 CELL; UPREGULATION;

ANIMAL; ANTIGEN PRESENTATION; ANTIGENS; ANTIGENS, CD; ANTIGENS, CD80; BRAIN; COCULTURE; DOWN-REGULATION; EPITOPES; GENE EXPRESSION REGULATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICROGLIA; MODELS, BIOLOGICAL; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; OVALBUMIN; SUPPORT, NON-U.S. GOV'T; TH1 CELLS; TH2 CELLS; UP-REGULATION;

EID: 0035542987     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.1127     Document Type: Article

References (39)

1. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotexicity mediated by small, resting T lymphocytes
2. B7-2 antigen is a second ligand for CTLA-4 and CD28
3. Lesioninduced myelin degeneration in vivo: Phagocytic microglia present antigens via MHC-II/B7-2(CD86) but not B7-1 (CD80) predicting neuroprotection
4. Morphological aspects of spinal cord autoimmune neuroprotection: Colocalization of T-cells with B7-2 (CD86) and prevention of cyst formation
5. Long term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation
6. Constitutive expression of costimulatory molecules by human microglia and its relevance to CNS autoimmunity
7. The organotypic entorhinalhippocampal complex slice culture of adolescent rats: A model to study transcellular changes in a circuit particularly vulnerable in neurodegenerative disorders
8. The costimulatery molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions
9. Murine B7-2, an alternative CTLA-4 counter-receptor that costimulates T-cell proliferation and interleukin 2 production
10. Cloning of B7-2: A CTLA-4 counter-receptor that costimulates human T-cell proliferation
11. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4
12. Antigen presentation and tumor cytotoxicity by interferon-γ-treated microglial cells
13. Tumor rejection requires a CTLA-4 ligand provided by the host or expressed on the tumor: Superiority of B7-1 over B7-2 for active tumor immunization
14. Axonal damage induced by invading T-cells in organotypic central nervous system tissue in vitro: Involvement of microglial cells
15. Th2 cells support intrinsic anti-inflammatory properties of the brain
16. A critical role for B7/CD28 costimulation in experimental autoimmune encephalomyelitis: A comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade
17. Resting microglial cells in vitro: Analysis of morphology and adhesion molecule expression in organotypic hippocampal slice cultures
18. Cellular interaction in germinal centers: Role of CD40 ligand and B7-2 in established germinal centers
19. Comparative analysis of B7-1 and B7-2 costimulatory ligands: Expression and function
20. Role of the CD28 receptor in T-cell activation
21. The B7 and CD28 receptor families
22. Tracing of the entorhinal-hippocampal pathway in vitro
23. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy
24. CD80 (B7-1) and CD86 (B7-2) provide similar costimulatory signals for T-cell proliferation, cytokine production, and generation of CTLA-4
25. Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies
26. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse
27. CD28/B7 system of T-cell costimulation
28. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1
29. Low avidity recognition of self-antigen by T-cells permits escape from central tolerance
30. Analysis of B7-1 and B7-2 costimulatory ligands in cultured mouse microglia: Upregulation by interferon-gamma and lipopolysaccharide and downregulation by interleukin-10, prostaglandin E2 and cyclic AMP-elevating agents
31. Blockade of CD28/B7-1 inter-action prevents epitope spreading and clinical relapses of murine EAE
32. Opposing effects of CTLA-4-Ig and anti-CD80 (B7-1) plus anti-CD86 (B7-2) on experimental allergic encephalomyelitis
33. Blockade of CD28 during in vitro activation of encephalitogenic T-cells or after disease onset ameliorates experimental autoimmune encephalomyelitis
34. Activation of regulatory cells suppresses experimental allergic encephalomyelitis via secretion of IL-10
35. Interaction of CTLA-4 (CD152) with CD80 or CD86 inhibits human T-cell activation
36. Treatment with intact anti-B7-1 mAb during disease remission enhances epitope spreading and exacerbates relapses in R-EAE
37. Neurotrophins and the anti-inflammatory agents interleukin-4 (IL-4), IL-10, IL-11 and transforming growth factor-beta1 (TGF-beta1) down-regulate T-cell costimulatory molecules B7 and CD40 on cultured rat microglia
38. B7/BB-1 antigen expression on adult human microglia studied in vitro and in situ
39. Expression of IL-12 and B7 costimulatory molecules in multiple sclerosis lesions